Correction: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

Bibliographic Details
Main Authors:	Chad J. Swanson, Yong Zhang, Shobha Dhadda, Jinping Wang, June Kaplow, Robert Y. K. Lai, Lars Lannfelt, Heather Bradley, Martin Rabe, Akihiko Koyama, Larisa Reyderman, Donald A. Berry, Scott Berry, Robert Gordon, Lynn D. Kramer, Jeffrey L. Cummings
Format:	Article
Language:	English
Published:	BMC 2022-05-01
Series:	Alzheimer’s Research & Therapy
Online Access:	https://doi.org/10.1186/s13195-022-00995-9

Internet